Updated November 18, 2024
The original post didn't age well.
You might also be interested in:
Compounding: Inspections, Recalls, and other Actions - FDA.gov
https://www.fda.gov/drugs/human-drug-compounding/compounding-inspections-recalls-and-other-actions
--- the original post follows below ---
Drug Safety and Availability > CDER Statement: FDA alerts pharmacies to concerns with testing conducted by Front Range Laboratories:
"In a recent inspection, FDA investigators observed that methods used by Front Range to assess sterility and other qualities (e.g., strength and stability) may have resulted in pharmacies receiving inaccurate laboratory test results. FDA has concerns that results obtained from Front Range are not reliable. FDA recommends that pharmacies not use this firm for sterility and other quality attributes testing at this time."
Return Home: The Designated Representative and Exemptee Blog
For Designated Representative license applicants - Training programs, courses, classes, seminars:
California (earn a training affidavit):- CA Designated Representative Wholesaler Training - Available around-the-clock 24 x 7
- CA Designated Representative 3PL Training
- CA Designated Representative Reverse Distributor Training
- The Designated Representative Institute
